Home
Zenas BioPharma

Zenas BioPharma Market Share Analysis for June 2026

We are all inspired to deliver on our commitment to patients with autoimmune disease.

Industry: N/A

Domainzenasbio.com

Year Founded2021

Employees51 - 200

Annual Revenue$10M - $15M

Zenas BioPharma

Zenas BioPharma (including company regionals)

zenasbio.com

See more website traffic and engagement information

Zenas BioPharma Revenue up to June 2026 is 10M - 15M

revenue generated by Zenas BioPharma top domains

Zenas BioPharma top domains revenue over 3 years

Revenue for Zenas BioPharma top domains

zenasbio.com10M - 15M

See more with Sales Intelligence

Total visits to Zenas BioPharma's top domains

Understand Zenas BioPharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

zenasbio.com9.4K

See more with Sales Intelligence

Avg. visit duration in Zenas BioPharma's top domains

Analyze Zenas BioPharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

zenasbio.com00:00:11

See more with Sales Intelligence

Avg. pageviews on Zenas BioPharma's top domains

See how Zenas BioPharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

zenasbio.com1.66

See more with Sales Intelligence

Zenas BioPharma top competitors by domain

Top similar sites in June 2026, ranked by their affinity

xencor.comCompany NameXencorEmployees201 - 500HQUnited States, California, MonroviaAnnual revenue$100M - $200MTotal visits10.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Zenas BioPharma

These are the website technologies, by industry, used by Zenas BioPharma top domains

Widget (4)

Twemoji

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

More Technologies

9

See all

News & Signals from Zenas BioPharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsZenas BioPharma, Inc. attended event H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit on Jun 11th '26.WALTHAM, Mass., June 11, 2026 (GLOBE NEWSWIRE) - Zenas BioPharma, Inc. ("Zenas," "Zenas BioPharma" or the "Company") (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced management's presentation at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit.

NewsZenas BioPharma, Inc. attended event EULAR 2026 Congress on Jun 5th '26.Zenas BioPharma recently announced groundbreaking data from the Phase 3 INDIGO trial of its lead candidate, Obexelimab, at the EULAR 2026 Congress, with concurrent publication in the New England Journal of Medicine(NEJM).

NewsZenas BioPharma, Inc. partnered with Innocarepharma on May 13th '26.ICP-054 is a novel potentially best-in-class oral small molecule IL-17AA/AF inhibitor being developed by InnoCare in partnership with Zenas BioPharma.